Table 2 Association between GRS and incidence of dyslipidaemia

 Q1

900

1.00 (reference)

1.00 (reference)

 Q2

898

1.110 (0.958, 1.287)

1.043 (0.900, 1.210)

 Q3

900

1.244 (1.077, 1.437)

1.188 (1.028, 1.374)

 Q4

898

1.276 (1.111, 1.466)

1.229 (1.069, 1.412)

Continuous GRS

3596

1.366 (1.187, 1.572)

1.353 (1.172, 1.561)

P _{for trend}

< 0.001

0.001

 Q1

633

1.00 (reference)

1.00 (reference)

 Q2

638

0.996 (0.834, 1.188)

1.023 (0.855, 1.223)

 Q3

624

1.182 (0.995, 1.404)

1.166 (0.979, 1.388)

 Q4

622

1.207 (1.023, 1.424)

1.213 (1.028, 1.433)

Continuous GRS

2517

1.337 (1.129, 1.584)

1.318 (1.110, 1.565)

P _{for trend}

0.006

0.008

 Q1

267

1.00 (reference)

1.00 (reference)

 Q2

260

1.456 (1.112, 1.907)

1.081 (0.820, 1.425)

 Q3

276

1.405 (1.080, 1.827)

1.225 (0.940, 1.596)

 Q4

276

1.454 (1.129, 1.874)

1.273 (0.986, 1.643)

Continuous GRS

1079

1.432 (1.113, 1.843)

1.466 (1.127, 1.907)

P _{for trend}

0.009

0.040